NASDAQ
Akebia Therapeutics, Inc. (AKBA)
♥ 378 Thanks from members
Akebia Therapeutics, Inc. (AKBA) exhibits mixed market sentiment, characterized by minor earnings and revenue fluctuations, short-term stock volatility ranging from $0.86 to $1.14, and long-term growth expectations anchored on product commercialization.